Nascent artificial intelligence (AI) group OWKIN is $11m in newly raised funds to hire medical specialists and prepare its proprietary Socrates technology platform for launch next year aimed at helping pharma R&D teams and hospital researchers discover and develop new targets, biomarkers and drugs faster.
The privately owned startup is building a privacy-preserving platform that uses machine-learning based modeling to analyze molecular and imaging libraries as well as patient datasets to uncover complex biomarker patterns that cause disease